NCT00728000 2019-11-25Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic AdenocarcinomaUniversity of CincinnatiPhase 2 Withdrawn
NCT01524575 2019-09-25Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1University of HawaiiPhase 2 Withdrawn
NCT01473303 2016-06-28Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic CancerAlliance for Clinical Trials in OncologyPhase 1/2 Withdrawn
NCT02575508 2016-05-20Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerRoswell Park Cancer InstitutePhase 1/2 Withdrawn